International Journal of Cancer Management

Published by: Neoscriber Demo Publisher
Crossmark

MTHFR C677T Polymorphism Is Associated with the Risk of Breast Cancer Among Kurdish Population from Western Iran

Zohreh Rahimi ORCID 1 , 2 , * , Maryam Bozorgi 1 , Ziba Rahimi 2 , Ebrahim Shakiba 1 , Kheirollah Yari 2 , Nazanin Jalilian 1 and Asad Vaisi-Raygani 3
Authors Information
1 Department of Clinical Biochemistry, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Article information
  • International Journal of Cancer Management: March 31, 2019, 12 (3); e67895
  • Published Online: March 12, 2019
  • Article Type: Research Article
  • Received: February 24, 2018
  • Revised: December 22, 2018
  • Accepted: February 19, 2019
  • DOI: 10.5812/ijcm.67895

To Cite: Rahimi Z, Bozorgi M, Rahimi Z, Shakiba E, Yari K, et al. MTHFR C677T Polymorphism Is Associated with the Risk of Breast Cancer Among Kurdish Population from Western Iran, Int J Cancer Manag. 2019 ; 12(3):e67895. doi: 10.5812/ijcm.67895.

Abstract
Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Yari K, Rahimi Z, Payandeh M, Rahimi Z. MMP-7 A-181G polymorphism in breast cancer patients from Western Iran. Breast Care (Basel). 2015;10(6):398-402. doi: 10.1159/000442231. [PubMed: 26989359]. [PubMed Central: PMC4789881].
  • 2. Yari K, Payandeh M, Rahimi Z. Association of the hypermethylation status of PTEN tumor suppressor gene with the risk of breast cancer among Kurdish population from Western Iran. Tumour Biol. 2016;37(6):8145-52. doi: 10.1007/s13277-015-4731-1. [PubMed: 26715274].
  • 3. Rahimi Z, Yari K, Rahimi Z. Matrix metalloproteinase-9 -1562T allele and its combination with MMP-2 -735 C allele are risk factors for breast cancer. Asian Pac J Cancer Prev. 2015;16(3):1175-9. doi: 10.7314/APJCP.2015.16.3.1175. [PubMed: 25735351].
  • 4. Rahimi Z, Bozorgi M, Shakiba E. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C variants, folate intake, and susceptibility to breast cancer. Int J Cancer Manag. 2017;10(11). doi: 10.5812/ijcm.9528.
  • 5. Waseem M, Hussain SR, Kumar S, Serajuddin M, Mahdi F, Sonkar SK, et al. Association of MTHFR (C677T) gene polymorphism with breast cancer in North India. Biomark Cancer. 2016;8:111-7. doi: 10.4137/BIC.S40446. [PubMed: 27721657]. [PubMed Central: PMC5040218].
  • 6. He JM, Pu YD, Wu YJ, Qin R, Zhang QJ, Sun YS, et al. Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer. Genet Mol Res. 2014;13(4):8925-31. doi: 10.4238/2014.October.31.7. [PubMed: 25366783].
  • 7. Jiang-Hua Q, De-Chuang J, Zhen-Duo L, Shu-de C, Zhenzhen L. Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes. Tumour Biol. 2014;35(12):11895-901. doi: 10.1007/s13277-014-2456-1. [PubMed: 25217320].
  • 8. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, et al. One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis. 2008;29(2):356-62. doi: 10.1093/carcin/bgm295. [PubMed: 18174236].
  • 9. Lajin B, Alhaj Sakur A, Ghabreau L, Alachkar A. Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumour Biol. 2012;33(4):1133-9. doi: 10.1007/s13277-012-0354-y. [PubMed: 22373582].
  • 10. Hosseini M, Houshmand M, Ebrahimi A. MTHFR polymorphisms and breast cancer risk. Arch Med Sci. 2011;7(1):134-7. doi: 10.5114/aoms.2011.20618. [PubMed: 22291746]. [PubMed Central: PMC3258688].
  • 11. Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T. Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: A case-control study in Thai women. Breast Cancer Res Treat. 2010;123(3):885-93. doi: 10.1007/s10549-010-0804-4. [PubMed: 20180013].
  • 12. Rahimi Z, Merat A, Gerard N, Krishnamoorthy R, Nagel RL. Implications of the genetic epidemiology of globin haplotypes linked to the sickle cell gene in southern Iran. Hum Biol. 2006;78(6):719-31. doi: 10.1353/hub.2007.0016. [PubMed: 17564250].
  • 13. Jafari Y, Rahimi Z, Vaisi-Raygani A, Rezaei M. Interaction of eNOS polymorphism with MTHFR variants increase the risk of diabetic nephropathy and its progression in type 2 diabetes mellitus patients. Mol Cell Biochem. 2011;353(1-2):23-34. doi: 10.1007/s11010-011-0770-0. [PubMed: 21380725].
  • 14. Sole X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: A web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928-9. doi: 10.1093/bioinformatics/btl268. [PubMed: 16720584].
  • 15. Papandreou CN, Doxani C, Zdoukopoulos N, Vlachostergios PJ, Hatzidaki E, Bakalos G, et al. Evidence of association between methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: A candidate-gene association study in a South-Eastern European population. DNA Cell Biol. 2012;31(2):193-8. doi: 10.1089/dna.2011.1292. [PubMed: 21875371].
  • 16. Ramos-Silva A, Figuera LE, Soto-Quintana OM, Puebla-Perez AM, Ramirez-Patino R, Gutierrez-Hurtado I, et al. Association of the C677T polymorphism in the methylenetetrahydrofolate reductase gene with breast cancer in a Mexican population. Genet Mol Res. 2015;14(2):4015-26. doi: 10.4238/2015.April.27.16. [PubMed: 25966173].
  • 17. Kotsopoulos J, Zhang WW, Zhang S, McCready D, Trudeau M, Zhang P, et al. Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat. 2008;112(3):585-93. doi: 10.1007/s10549-008-9895-6. [PubMed: 18204969].
  • 18. Zhong S, Chen Z, Yu X, Li W, Tang J, Zhao J. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer. Mol Biol Rep. 2014;41(9):5775-85. doi: 10.1007/s11033-014-3450-9. [PubMed: 24973876].
  • 19. Xie SZ, Liu ZZ, Yu JH, Liu L, Wang W, Xie DL, et al. Association between the MTHFR C677T polymorphism and risk of cancer: Evidence from 446 case-control studies. Tumour Biol. 2015;36(11):8953-72. doi: 10.1007/s13277-015-3648-z. [PubMed: 26081619].
  • 20. Kumar P, Yadav U, Rai V. Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility. Meta Gene. 2015;6:72-84. doi: 10.1016/j.mgene.2015.08.008. [PubMed: 26629412]. [PubMed Central: PMC4634353].
  • 21. Zhang Y, Jia H, Wang S, Jiang D. Cumulative review and meta-analyses on the association between MTHFR rs1801133 polymorphism and breast cancer risk: A pooled analysis of 83 studies with 74,019 participants. Minerva Med. 2017;108(1):57-73. doi: 10.23736/S0026-4806.16.04759-5. [PubMed: 27824246].
  • 22. Naushad SM, Pavani A, Rupasree Y, Divyya S, Deepti S, Digumarti RR, et al. Association of aberrations in one-carbon metabolism with molecular phenotype and grade of breast cancer. Mol Carcinog. 2012;51 Suppl 1:E32-41. doi: 10.1002/mc.21830. [PubMed: 22086855].
  • 23. Rezende LM, Marson FAL, Lima CSP, Bertuzzo CS. Can MTHFR C677T and A1298C polymorphisms alter the risk and severity of sporadic breast cancer in Brazilian women? Clin Breast Cancer. 2017;17(4):e199-208. doi: 10.1016/j.clbc.2017.02.004. [PubMed: 28330681].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments